Khuong Chau Quang

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 62% 68% 82%
Transactions
18 22% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Khuong Chau Quang's trades of Fusion Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
371.47
Quantity 17,479
Value US$4,736,468
Transaction date
Proposed sale
Price
104.83
Quantity 10,257
Value US$3,627,023
US Galecto Inc (GLTO)
Transaction date
Purchase
Price
353.09
Quantity 41,427 +48.3%
Value US$3,756,324
US Galecto Inc (GLTO)
Transaction date
Purchase
Price
15.00
Quantity 523,833 +25.5%
Value US$7,857,495
US NextCure Inc (NXTC)
Transaction date
Purchase
Price
15.00
Quantity 350,000 +14.8%
Value US$5,250,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-12-14 2023-12-14
PrS Proposed sale
17,479
371.47
US$4,736,468 		17,479 371.47 US$4,736,468
2023-12-08 2023-12-08
PrS Proposed sale
10,257
104.83
US$3,627,023 		10,257 104.83 US$3,627,023
2020-11-04 2020-11-02
US Galecto Inc (GLTO)
B Purchase
41,427 +48.3%
353.09
US$3,756,324 		41,427 +48.3% 353.09 US$3,756,324
2020-11-04 2020-11-02
US Galecto Inc (GLTO)
B Purchase
523,833 +25.5%
15.00
US$7,857,495 		523,833 +25.5% 15.00 US$7,857,495
2020-08-19 2020-08-18
S Sale
43,543 -100.0%
108.54
US$4,726,157 		43,543 -100.0% 108.54 US$4,726,157
2020-08-19 2020-08-17
S Sale
94,900 -68.5%
107.49
US$10,200,801 		94,900 -68.5% 107.49 US$10,200,801
2020-08-14 2020-08-14
S Sale
20,237 -12.8%
109.03
US$2,206,440 		20,237 -12.8% 109.03 US$2,206,440
2020-08-14 2020-08-13
S Sale
29,251 -15.6%
109.93
US$3,215,562 		29,251 -15.6% 109.93 US$3,215,562
2020-08-14 2020-08-12
S Sale
42,679 -18.5%
107.45
US$4,585,859 		42,679 -18.5% 107.45 US$4,585,859
2020-08-11 2020-08-11
S Sale
39,877 -14.8%
105.78
US$4,218,189 		39,877 -14.8% 105.78 US$4,218,189
2020-08-11 2020-08-10
S Sale
47,700 -15.0%
105.23
US$5,019,471 		47,700 -15.0% 105.23 US$5,019,471
2020-08-11 2020-08-07
S Sale
28,993 -8.4%
106.18
US$3,078,477 		28,993 -8.4% 106.18 US$3,078,477
2020-07-02 2020-06-30
B Purchase
192,100 +inf%
17.00
US$3,265,700 		192,100 +inf% 17.00 US$3,265,700
2020-07-02 2020-06-30
B Purchase
705,900 +31.7%
17.00
US$12,000,300 		705,900 +31.7% 17.00 US$12,000,300
2020-03-10 2020-03-06
S Sale
500,000 -59.0%
83.52
US$41,760,000 		500,000 -59.0% 83.52 US$41,760,000
2020-03-05 2020-03-04
S Sale
400,000 -32.1%
84.42
US$33,768,000 		400,000 -32.1% 84.42 US$33,768,000
2020-03-05 2020-03-04
S Sale
25,000 -2.0%
84.55
US$2,113,750 		25,000 -2.0% 84.55 US$2,113,750
2020-03-05 2020-03-03
S Sale
75,000 -5.6%
83.21
US$6,240,750 		75,000 -5.6% 83.21 US$6,240,750
2019-05-13 2019-05-13
US NextCure Inc (NXTC)
B Purchase
350,000 +14.8%
15.00
US$5,250,000 		350,000 +14.8% 15.00 US$5,250,000
2019-03-11 2019-03-08
S Sale
290,231 -16.5%
57.75
US$16,760,840 		290,231 -16.5% 57.75 US$16,760,840
2019-03-11 2019-03-07
S Sale
68,218 -3.7%
55.01
US$3,752,672 		68,218 -3.7% 55.01 US$3,752,672